PARP1 and colorectal carcinoma: Further research revealed that NUDT13 suppresses PARP1‐mediated PKM1 PARylation, stabilizes PKM1 protein, and induces an oxidative phosphorylation phenotype in CRC cells, thereby significantly inhibiting tumorigenesis; Nudix motif‐targeted peptides can block CRC progression [167].